Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | CEO, Imaging | May 13, 2024 | May 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date May 13, 2024 · Filed May 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 63,348 |
Ending reported balance
After 2024-05-15 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-05-13 · Exercise / conversion · Acquired 20,227 · Balance 83,575 Row 2 · 2024-05-13 · Sale · Disposed 20,227 · Balance 63,348 F1: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Row 3 · 2024-05-15 · Exercise / conversion · Acquired 8,388 · Balance 71,736 Row 4 · 2024-05-15 · Exercise / conversion · Acquired 25,472 · Balance 97,208 Row 5 · 2024-05-15 · Exercise / conversion · Acquired 33,095 · Balance 130,303 Row 6 · 2024-05-15 · Sale · Disposed 66,955 · Balance 63,348 F2: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.51 · Expires 2030-03-02 | Direct | 8,388 |
Reported balance
After 2024-05-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-05-13 · Exercise / conversion · Disposed 20,227 · Balance 8,388 F3: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.51 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2024-05-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-05-15 · Exercise / conversion · Disposed 8,388 · Balance 0 F3: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $75.30 · Expires 2033-03-01 | Direct | 0 |
Reported balance
After 2024-05-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-05-15 · Exercise / conversion · Disposed 25,472 · Balance 0 F4: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.37 · Expires 2031-07-01 | Direct | 33,096 |
Reported balance
After 2024-05-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-05-15 · Exercise / conversion · Disposed 33,095 · Balance 33,096 F5: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023.
F4: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024.
F5: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,095 | $0.00 Strike: $76.37 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 10 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,096 Underlying: Common Stock, par value $0.01 per share · 33,095 shares Expires 2031-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,472 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 9 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 25,472 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,388 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 8 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,388 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 66,955 | $81.54 | $5,459,510.70 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 33,095 | $76.37 | $2,527,465.15 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 25,472 | $75.30 | $1,918,041.60 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 8,388 | $63.51 | $532,721.88 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,227 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 7 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,388 Underlying: Common Stock, par value $0.01 per share · 20,227 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 20,227 | $81.57 | $1,649,916.39 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| May 13, 2024 Filed May 15, 2024 23:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 20,227 | $63.51 | $1,284,616.77 |
DisclosureSEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 23,006 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · derivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,006 Underlying: Common Stock, par value $0.01 per share · 23,006 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 8,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 8,154 | $91.28 | $744,297.12 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,260 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 4,292 | $91.28 | $391,773.76 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,414 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,424 | $91.28 | $312,542.72 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,706 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,489 | $91.28 | $318,475.92 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,130 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 4,596 | $76.19 | $350,169.24 |
DisclosureSEC source: 0001628280-23-027759 · wk-form4_1691438712.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,271 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:07 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,929 | $80.36 | $155,014.44 |
DisclosureSEC source: 0001628280-23-024233 · wk-form4_1688587655.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,867 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,037 | $0.00 Strike: $51.67 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 10 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 4,037 shares Expires 2029-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 54,701 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 9 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 54,701 shares Expires 2028-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $57.74 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 8 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,967 shares Expires 2029-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 240 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 7 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 240 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 5,684 | $78.07 | $443,749.88 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,796 F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.23, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 64,945 | $77.66 | $5,043,628.70 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,480 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.89 to $78.28, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 4,037 | $51.67 | $208,591.79 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 54,701 | $40.40 | $2,209,920.40 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 5,967 | $57.74 | $344,534.58 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 240 | $63.51 | $15,242.40 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,525 | $75.04 | $114,436.00 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,480 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 25,472 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · derivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472 Underlying: Common Stock, par value $0.01 per share · 25,472 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,489 | $75.30 | $262,721.70 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,005 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 9,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,494 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 09, 2023 Filed Dec 29, 2023 23:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 17,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-042949 · wk-form4_1703890929.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,619 F1 · date: Inadvertently filed late due to an administrative error. F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:00 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 43,112 | Not disclosed Strike: $70.01 | Not disclosed |
DisclosureSEC source: 0001628280-23-002256 · wf-form4_167546517834556.xml · derivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,112 Underlying: Common Stock, par value $0.01 per share · 43,112 shares Expires 2033-02-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:00 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-002256 · wf-form4_167546517834556.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,364 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 4,910 newly awarded restricted stock units, 60,422 previously reported restricted stock units, and 32 shares of common stock. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 14,569 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 17 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,569 Underlying: Common stock, par value $0.01 per share · 14,569 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F10 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F10 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 8,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 16 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,209 Underlying: Common stock, par value $0.01 per share · 8,209 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F9 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024. F9 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 14,846 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 15 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,846 Underlying: Common stock, par value $0.01 per share · 14,846 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 19,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 14 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,555 Underlying: Common stock, par value $0.01 per share · 19,555 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 3,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 13 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,243 Underlying: Common stock, par value $0.01 per share · 3,243 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 66,191 | Not disclosed Strike: $76.37 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 12 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,191 Underlying: Common stock, par value $0.01 per share · 66,191 shares Expires 2031-07-01 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 28,615 | Not disclosed Strike: $63.51 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 11 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,615 Underlying: Common stock, par value $0.01 per share · 28,615 shares Expires 2030-03-02 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 240 | Not disclosed Strike: $63.51 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 10 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240 Underlying: Common stock, par value $0.01 per share · 240 shares Expires 2030-03-02 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 4,037 | Not disclosed Strike: $51.67 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 9 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,037 Underlying: Common stock, par value $0.01 per share · 4,037 shares Expires 2029-04-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 5,967 | Not disclosed Strike: $57.74 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 8 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common stock, par value $0.01 per share · 5,967 shares Expires 2029-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 54,701 | Not disclosed Strike: $40.40 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 7 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,701 Underlying: Common stock, par value $0.01 per share · 54,701 shares Expires 2028-12-21 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 7,345 | Not disclosed Strike: $161.30 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,345 Underlying: Common stock, par value $0.01 per share · 7,345 shares Expires 2026-09-30 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 4,408 | Not disclosed Strike: $135.92 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,408 Underlying: Common stock, par value $0.01 per share · 4,408 shares Expires 2025-09-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 2,328 | Not disclosed Strike: $142.15 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,328 Underlying: Common stock, par value $0.01 per share · 2,328 shares Expires 2024-09-05 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 206 | Not disclosed Strike: $142.15 | Not disclosed |
DisclosureSEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206 Underlying: Common stock, par value $0.01 per share · 206 shares Expires 2024-09-05 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.